Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone mineral density, a ...

(Reuters) -Amgen said on Wednesday there was no link between its experimental weight-loss drug and changes in bone density, a ...

Analysts cited data from a phase one study showing the highest dose of Amgen’s MariTide was linked to roughly 4% loss of bone ...

Supplementation with cholecalciferol 1,000 IU/day during pregnancy is associated with greater offspring bone mineral density ...

Amgen’s stock fell 7% after an analyst posted a note on MariTide’s influence on bone density which was noticed in a data ...

HEALTH LITERACY: Understanding osteoporosis: Causes, risk factors, and preventive strategies for bone health ...

Lung transplant patients should undergo annual bone health screenings using dual-energy X-ray absorptiometry for the first ...

Investigators used 3-dimensional quantitative computed tomography to more accurately assess patients’ bone mineral density.

Amgen addresses safety concerns for its weight loss drug MariTide after new data suggests a potential 4% reduction in bone ...

Research indicates that vitamin D supplementation during pregnancy positively impacts children's bone health and lean mass, ...

Cantor analysts said they found the bone mineral density changes when reviewing supplemental data that was published along ...

Amgen Inc.'s stock dropped over 7% on Tuesday following revelations about bone density loss in early trials of its ...